Global
News Centre
Company News

Year

2025
2024
2023
2022
2021
2020
2019
2018

Month

01
02
03
04
05
06
07
08
09
10
11
12
2025-01-22 10:43
Lepu Biopharma has granted Arr...
Today, Lepu Biopharma Co., Ltd (Stock Code: 02157.HK) announced that it has entered into an exclusive licensing agreement with ArriVent BioPharma, Inc. (Nasdaq: AVBP) for MRG007, a Potential...
More
2024-05-24 12:34
VOLUNTARY ANNOUNCEMENT THREE C
A. INTRODUCTION   This announcement is made by Lepu Biopharma Co., Ltd. (the “Company”) on a voluntarybasis.   The board of directors of the Company (the “Board...
More
2024-03-11 18:29
FAST TRACK DESIGNATION GRANTED...
March 11, 2024，Lepu Biopharma Co., Ltd. (the “Company”) announce that, our drug candidate MRG004A, a novel tissue factor-targeted site-specifically conjugated antibody drug conjugate, has ...
More
2023-12-29 10:37
COMPLETION OF PATIENT ENROLLME...
29 December, 2023, Lepu Biopharma Co., Ltd. (Stock Code: 02157.HK) is pleased to announce that, our drug candidate MRG003, an antibody drug conjugate (“ADC”) drug candidate targeting epide...
More
<12345
Home Page
Company Profile
Strategic Investors
Technical Strength
News Centre
About Us
Company Profile
Milestones
Core Team
Science and Technology
Research Field
Technology Platform
Product Pipeline
Manufacturing Plants
Intellectual Property Rights
Investor Relations
Company Information
Financial Reports
Announcements and Circulars
Corporate Governance
News Centre
Company News
Join Us
Corporate Culture
Business Outlook
Benefits
Job Opportunities
Contact us
Copyright 2021 By Lepu Biopharma CO.,Ltd.
沪ICP备2025126058-1

Home Page
About Us
Science and Technology
Strategic Investors
News Centre
Join Us
Contact Us